SI-BONE out of San Jose, CA is anticipating European approval of its iFuse Implant System for fusion procedures of sacroiliac joints. In preparation, the company is launching training sessions to get European surgeons on board to use the device that has already received FDA approval two years ago.
The iFuse Implant System is a minimally invasive surgical (MIS) system comprised of titanium implants coated with a porous plasma spray that acts as an interference surface fit, which helps decrease implant motion. The iFuse has a substantial thickness and sophisticated metallurgy, which provide immediate post-operative fixation, accomplishing the goal of traditional open SI Joint fusion through an MIS approach.
Less invasive approach than open surgical procedure
* Minimal incision size
* Minimal soft tissue stripping
* Minimal tendon irritation
* Reduced risk of infection
Simpler approach than open surgical procedure
* Just pin, drill, broach, insert implant and close
* Cannulated delivery system
* Simple technique reduces OR time < 1 hour
* Minimal blood loss
* Less post-surgical call-back to OR
* Fewer complications
Decreased length of hospital stay
* < 1 day compared to 3-4 days with open surgery